“Characterization of ORKA-001, a Novel Extended Half-Life Monoclonal Antibody Targeting IL-23 for the Treatment of Psoriasis”. 2025. SKIN The Journal of Cutaneous Medicine 9 (2): s527. https://doi.org/10.25251/skin.10.supp.527.